Analysed PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) News Sources
Phathom Pharmaceuticals (PHAT) Is Up 11.0% After Narrowing Q1 Loss And Reaffirming 2026 Profitability Timeline
05-05-2026
yahoo.com
Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting
20-05-2026
yahoo.com
Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)
23-06-2026
yahoo.com
Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026
20-07-2026
yahoo.com
Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
30-07-2026
yahoo.com
Phathom Pharmaceuticals Inc (PHAT) (Q2 2026) Earnings Call Highlights: First Positive Operating ...
30-07-2026
yahoo.com
What is the current price of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The current price of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is $8.75.
PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) absolute price change since previous trading day?
The absolute price change of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) since the previous trading day is $-0.28.
PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) percentage price change since previous trading day?
The percentage price change of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) since the previous trading day is -3.1008%.
What is the most recent average sentiment score for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The most recent average sentiment score for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The most recent sentiment for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is .
SEC-8K** Filing Available For PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.